カテゴリ： 世界, 医療/バイオ, Bizwit Research & Consulting

アトピー性皮膚炎薬のグローバル市場（2022年-2029年）：副腎皮質ホルモン、カルシニューリン阻害剤、PDE4阻害剤、バイオ製剤、その他

■ 英語タイトル：Global Atopic Dermatitis Drugs Market Size study & Forecast, by Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others) by Route of Administration (Topical, Injectable, Oral) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23FE0088）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23FE0088
■ 発行日：2023年2月8日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医薬品
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥950,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アトピー性皮膚炎薬のグローバル市場（2022年-2029年）：副腎皮質ホルモン、カルシニューリン阻害剤、PDE4阻害剤、バイオ製剤、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の市場調査書によると、2021年に約127.1億ドルであった世界のアトピー性皮膚炎薬市場規模は、2022年から2029年の間に年平均9％拡大すると予測されています。当書は、アトピー性皮膚炎薬の世界市場を対象にし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、クラス別（副腎皮質ホルモン、カルシニューリン阻害剤、PDE4阻害剤、バイオ製剤、その他）分析、投与経路別（外用、注射剤、経口剤）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目について調査を行いました。なお、当書には、Pfizer Inc.、Sanofi、AbbVie Inc.、GALDERMA LABORATORIES, L.P.、Eli Lilly and Company (Dermira)、Regeneron Pharmaceuticals Inc.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界アトピー性皮膚炎薬市場規模：クラス別
- 副腎皮質ホルモンの市場規模
- カルシニューリン阻害剤の市場規模
- PDE4阻害剤の市場規模
- バイオ製剤の市場規模
- その他アトピー性皮膚炎薬の市場規模
・世界アトピー性皮膚炎薬市場規模：投与経路別
- 外用における市場規模
- 注射剤における市場規模
- 経口剤における市場規模
・世界のアトピー性皮膚炎薬市場規模：地域別
- 北米のアトピー性皮膚炎薬市場
- ヨーロッパのアトピー性皮膚炎薬市場
- アジア太平洋のアトピー性皮膚炎薬市場
- 中南米のアトピー性皮膚炎薬市場
- その他地域のアトピー性皮膚炎薬市場
・競争分析
・調査プロセス

Global Atopic Dermatitis Drugs Market is valued at approximately USD 12.71 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2029. Atopic dermatitis also known as eczema is a chronic, inflammatory skin, and non-contagious condition which affects the skin and leads to red, dry, itchy, and bumpy. The rise in awareness regarding the product availability for the disease, and robust product portfolio, coupled with the increasing expenditure on healthcare services and products are bolstering the market demand worldwide.

The rising incidences of atopic dermatitis is propelling the market demand across the globe. The Acta Derm Venereological Journal reported that in 2020 the doctor diagnosed that the prevalence of atopic dermatitis in adults varied from 17.1% in Europe to 10.2% in Asia; in children, the rates were 22.6% and 0.96%, respectively. Thereby, the high incidences of atopic dermatitis among the population are reinforcing the need for atopic dermatitis drugs to receive timely and suitable treatment, which, in turn, augments the growth of the market. Moreover, increasing product approvals, as well as the growing R&D investments by the key market players present various lucrative opportunities over the forecasting years. However, the high cost of therapeutics and some side effects associated with drugs are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Atopic Dermatitis Drugs Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing R&D investment and presence of well-established healthcare infrastructure. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increase in pro-health initiatives, rise in consumer awareness, as well as strong healthcare reimbursement systems in the market space.

Major market players included in this report are:
Pfizer Inc.
Sanofi
AbbVie Inc.
GALDERMA LABORATORIES, L.P.
Eli Lilly and Company (Dermira)
Regeneron Pharmaceuticals Inc.
LEO Pharma Inc.
Otsuka Pharmaceutical Co., Ltd.
Novartis AG
Incyte Corporation

Recent Developments in the Market:
 In April 2021, AbbVie declared that the company is strengthening its supplemental New Drug Application (sNDA) to review RINVOQ for atopic dermatitis adolescent and adult patients. The Prescription Drug User Fee Act (PDUFA) was extended till quarter 3 of 2021.

Global Atopic Dermatitis Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Class, Route of Administration, , Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Class:
Corticosteroids
Calcineurin Inhibitors
PDE4 Inhibitors
Biologics
Others

By Route of Administration:
Topical
Injectable
Oral

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Atopic Dermatitis Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Atopic Dermatitis Drugs Market, by Class, 2019-2029 (USD Billion)
1.2.3. Atopic Dermatitis Drugs Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Atopic Dermatitis Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Atopic Dermatitis Drugs Market Dynamics
3.1. Atopic Dermatitis Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Robust product portfolio
3.1.1.2. Increasing incidences of atopic dermatitis
3.1.2. Market Challenges
3.1.2.1. High cost of therapeutics
3.1.2.2. Some side-effects associated with drugs
3.1.3. Market Opportunities
3.1.3.1. Increasing product approvals
3.1.3.2. Growing R&D investments by the key market players
Chapter 4. Global Atopic Dermatitis Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Atopic Dermatitis Drugs Market, by Class
6.1. Market Snapshot
6.2. Global Atopic Dermatitis Drugs Market by Class, Performance – Potential Analysis
6.3. Global Atopic Dermatitis Drugs Market Estimates & Forecasts by Class 2019-2029 (USD Billion)
6.4. Atopic Dermatitis Drugs Market, Sub Segment Analysis
6.4.1. Corticosteroids
6.4.2. Calcineurin Inhibitors
6.4.3. PDE4 Inhibitors
6.4.4. Biologics
6.4.5. Others
Chapter 7. Global Atopic Dermatitis Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Atopic Dermatitis Drugs Market by Route of Administration, Performance – Potential Analysis
7.3. Global Atopic Dermatitis Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Atopic Dermatitis Drugs Market, Sub Segment Analysis
7.4.1. Topical
7.4.2. Injectable
7.4.3. Oral
Chapter 8. Global Atopic Dermatitis Drugs Market, Regional Analysis
8.1. Atopic Dermatitis Drugs Market, Regional Market Snapshot
8.2. North America Atopic Dermatitis Drugs Market
8.2.1. U.S. Atopic Dermatitis Drugs Market
8.2.1.1. Class breakdown estimates & forecasts, 2019-2029
8.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Atopic Dermatitis Drugs Market
8.3. Europe Atopic Dermatitis Drugs Market Snapshot
8.3.1. U.K. Atopic Dermatitis Drugs Market
8.3.2. Germany Atopic Dermatitis Drugs Market
8.3.3. France Atopic Dermatitis Drugs Market
8.3.4. Spain Atopic Dermatitis Drugs Market
8.3.5. Italy Atopic Dermatitis Drugs Market
8.3.6. Rest of Europe Atopic Dermatitis Drugs Market
8.4. Asia-Pacific Atopic Dermatitis Drugs Market Snapshot
8.4.1. China Atopic Dermatitis Drugs Market
8.4.2. India Atopic Dermatitis Drugs Market
8.4.3. Japan Atopic Dermatitis Drugs Market
8.4.4. Australia Atopic Dermatitis Drugs Market
8.4.5. South Korea Atopic Dermatitis Drugs Market
8.4.6. Rest of Asia Pacific Atopic Dermatitis Drugs Market
8.5. Latin America Atopic Dermatitis Drugs Market Snapshot
8.5.1. Brazil Atopic Dermatitis Drugs Market
8.5.2. Mexico Atopic Dermatitis Drugs Market
8.5.3. Rest of Latin America Atopic Dermatitis Drugs Market
8.6. Rest of The World Atopic Dermatitis Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Sanofi
9.2.3. AbbVie Inc.
9.2.4. GALDERMA LABORATORIES, L.P.
9.2.5. Eli Lilly and Company (Dermira)
9.2.6. Regeneron Pharmaceuticals Inc.
9.2.7. LEO Pharma Inc.
9.2.8. Otsuka Pharmaceutical Co., Ltd.
9.2.9. Novartis AG
9.2.10. Incyte Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Atopic Dermatitis Drugs Market, report scope
TABLE 2. Global Atopic Dermatitis Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Atopic Dermatitis Drugs Market estimates & forecasts by Class 2019-2029 (USD Billion)
TABLE 4. Global Atopic Dermatitis Drugs Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 5. Global Atopic Dermatitis Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Atopic Dermatitis Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Atopic Dermatitis Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Atopic Dermatitis Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Atopic Dermatitis Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Atopic Dermatitis Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Atopic Dermatitis Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Atopic Dermatitis Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Atopic Dermatitis Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Atopic Dermatitis Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Atopic Dermatitis Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Atopic Dermatitis Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Atopic Dermatitis Drugs Market
TABLE 70. List of primary sources, used in the study of global Atopic Dermatitis Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • うっ血性心不全薬のグローバル市場（2022年-2029年）：ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他
  • NPK（窒素・リン酸・カリウム）のグローバル市場（2022年-2029年）：ニトロリン酸塩、リン酸、固形物造粒、圧縮
  • 船舶自動識別装置（AIS）のグローバル市場（2022年-2029年）：クラスA、クラスB、AISベースステーション
  • 医薬品添加剤のグローバル市場（2022年-2029年）：有機化学品（炭水化物）、無機化学品（リン酸カルシウム）
  • バイオプロセス分析器のグローバル市場（2022年-2029年）：機器、消耗品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23FE0088 )"アトピー性皮膚炎薬のグローバル市場（2022年-2029年）：副腎皮質ホルモン、カルシニューリン阻害剤、PDE4阻害剤、バイオ製剤、その他" (英文：Global Atopic Dermatitis Drugs Market Size study & Forecast, by Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others) by Route of Administration (Topical, Injectable, Oral) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。